Zhejiang Orient Gene Biotech Co., Ltd. (688298.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 18.06

From 52W high−10.69%

Volume2.06M

Market capCNY 3.77B

P/E (TTM)−6.6x

P/S (TTM)3.6x

Div yield—

Key dataSep 18, 2026

Open

CNY 18.06

From 52W high

−10.69%

Volume

2.06M

Market cap

CNY 3.77B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.4x

P/E (TTM)

−6.6x

RSI (14)

37.6

MomentumView details →

1D Return

−3.71%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−6.6x

EV/EBITDA

−4.4x

EV/Sales

1.6x

P/S (TTM)

3.6x

P/B (TTM)

0.6x

ProfitabilityView details →

Gross Margin

43.88%

Net Margin

−54.56%

EBITDA Margin

−37.51%

ROE (TTM)

−9.37%

ROA (TTM)

−8.01%

Asset Turnover

0.14x

GrowthView details →

Revenue YoY

+20.88%

EPS YoY

+1.34%

FCF YoY

+55.40%

Revenue CAGR 3Y

−52.37%

EPS CAGR 3Y

−10.78%

EBITDA YoY

—

MomentumView details →

1D Return

−3.71%

YTD Return

—

1Y Return

—

RSI (14)

37.6

vs 50D SMA

−6.08%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

3.79x

Quick Ratio

3.42x

Div Yield

—

Div Rate

—

Div Growth 1Y

−67.64%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.01B

Net Income (TTM)

−551.99M

Op. CF (TTM)

−168.72M

Latest newsMore news →

Zhejiang Orient Gene Biotech stated that its quantum dot flow fluorescence equipment and reagents have obtained multiple domestic and international certificates, have been gradually industrialized, and have entered domestic and international markets.10d ago

At its 2026 interim online results briefing held on September 10, Zhejiang Orient Gene Biotech stated that it has developed high-quality Ebola antigen detection and nucleic acid detection reagents and has laid out detection reagents for other vector-borne diseases.10d ago

Similar companies

安旭生物688075.SH 健麾信息605186.SH 祥生医疗688358.SH Jenscare Scientific Co., Ltd.09877.HK 普门科技688389.SH Ekso Bionics Holdings, Inc. Common StockCHRN Find similar companies →

Latest newsMore news →

Zhejiang Orient Gene Biotech stated that its quantum dot flow fluorescence equipment and reagents have obtained multiple domestic and international certificates, have been gradually industrialized, and have entered domestic and international markets.10d ago At its 2026 interim online results briefing held on September 10, Zhejiang Orient Gene Biotech stated that it has developed high-quality Ebola antigen detection and nucleic acid detection reagents and has laid out detection reagents for other vector-borne diseases.10d ago OriGene Biotech and its wholly-owned subsidiary Shanghai Wanzijian Bio recently obtained multiple medical device registration certificates in China and overseas, covering syphilis antibody detection, HPV nucleic acid typing, and thyroid-stimulating hormone detection products.17d ago